{"id":1773,"date":"2023-03-12T15:56:57","date_gmt":"2023-03-12T15:56:57","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=1773"},"modified":"2023-03-12T15:56:58","modified_gmt":"2023-03-12T15:56:58","slug":"bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/","title":{"rendered":"Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"271\" height=\"107\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/logo-76.jpg\" alt=\"Logo of Bicara Therapeutics\" class=\"wp-image-1775\" \/><\/figure>\n\n\n\n<p><a href=\"https:\/\/www.bicara.com\/\">Bicara Therapeutics<\/a>, a Cambridge-based biotechnology research startup, has raised an impressive $108M in Series B funding from a range of investors including <a href=\"https:\/\/eightroads.com\/en\/\">Eight Roads<\/a>, <a href=\"https:\/\/fprimecapital.com\/\">F-Prime Capital<\/a>, <a href=\"https:\/\/www.invus.com\/\">The Invus Group<\/a>, <a href=\"https:\/\/omegafunds.com\/\">Omega Funds<\/a>, <a href=\"https:\/\/www.racap.com\/\">RA Capital Management<\/a>, <a href=\"https:\/\/www.pipersandler.com\/\">Piper Sandler<\/a>, <a href=\"https:\/\/www.janushenderson.com\/en\/row\/documents\/\">Janus Henderson Investors<\/a>, <a href=\"http:\/\/www.acornbioventures.com\/\">Acorn Bioventures<\/a>, <a href=\"https:\/\/www.bioqubeventures.com\/\">Bioqube Ventures<\/a>, and <a href=\"https:\/\/redtreevc.com\/\">Red Tree Venture Capital<\/a>. The company, founded by <a href=\"https:\/\/www.linkedin.com\/in\/claire-mazumdar-bb53815a\/\">Claire Mazumdar<\/a>, is dedicated to developing bifunctional antibodies and other biologics for the treatment of solid tumors. Their lead program focuses on inhibiting the epidermal growth factor receptor (EGFR) and disabling transforming growth factor beta (TGF-\u03b2), a molecule that promotes tumor growth, directly at the site of the tumor. By targeting both of these mechanisms, they hope to achieve superior anti-tumor efficacy with an improved therapeutic window.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"679\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/team-29-1024x679.jpg\" alt=\"Team at Bicara Therapeutics\" class=\"wp-image-1774\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/team-29-1024x679.jpg 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/team-29-300x199.jpg 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/team-29-768x509.jpg 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/team-29.jpg 1169w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Bicara&#8217;s strength lies in their platform, which allows them to design bifunctional molecules that precisely target the tumor and deliver the tumor-modulating payload, minimizing side effects. Additionally, by effectively delivering the immune-modulating payload to the tumor, lower doses of drug may be required for anti-tumor effect, resulting in less toxicity to healthy tissues elsewhere in the body. With a deep pipeline of promising bifunctional antibodies, Bicara is set to make significant strides in the treatment of solid tumors. Their innovative approach to cancer treatment has caught the attention of investors, positioning Bicara for future success in the biotechnology industry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bicara Therapeutics, a Cambridge-based biotechnology research startup, has raised an impressive $108M in Series B funding from a range of investors including Eight Roads, F-Prime Capital, The Invus Group, Omega Funds, RA Capital Management, Piper Sandler, Janus Henderson Investors, Acorn Bioventures, Bioqube Ventures, and Red Tree Venture Capital. The company, founded by Claire Mazumdar, is [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":1776,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding - Founder Lodge Latest News<\/title>\n<meta name=\"description\" content=\"Bicara Therapeutics, a Cambridge-based biotechnology research startup, has raised an impressive $108M in Series B funding from a range of investors\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding - Founder Lodge Latest News\" \/>\n<meta property=\"og:description\" content=\"Bicara Therapeutics, a Cambridge-based biotechnology research startup, has raised an impressive $108M in Series B funding from a range of investors\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-12T15:56:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-12T15:56:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/landing-28.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1802\" \/>\n\t<meta property=\"og:image:height\" content=\"856\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"fasihsheikh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fasihsheikh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/\"},\"author\":{\"name\":\"fasihsheikh\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8\"},\"headline\":\"Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding\",\"datePublished\":\"2023-03-12T15:56:57+00:00\",\"dateModified\":\"2023-03-12T15:56:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/\"},\"wordCount\":233,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/\",\"name\":\"Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding - Founder Lodge Latest News\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-03-12T15:56:57+00:00\",\"dateModified\":\"2023-03-12T15:56:58+00:00\",\"description\":\"Bicara Therapeutics, a Cambridge-based biotechnology research startup, has raised an impressive $108M in Series B funding from a range of investors\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8\",\"name\":\"fasihsheikh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g\",\"caption\":\"fasihsheikh\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/fasihsheikh\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding - Founder Lodge Latest News","description":"Bicara Therapeutics, a Cambridge-based biotechnology research startup, has raised an impressive $108M in Series B funding from a range of investors","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/","og_locale":"en_US","og_type":"article","og_title":"Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding - Founder Lodge Latest News","og_description":"Bicara Therapeutics, a Cambridge-based biotechnology research startup, has raised an impressive $108M in Series B funding from a range of investors","og_url":"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-03-12T15:56:57+00:00","article_modified_time":"2023-03-12T15:56:58+00:00","og_image":[{"width":1802,"height":856,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/landing-28.jpg","type":"image\/jpeg"}],"author":"fasihsheikh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"fasihsheikh","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/"},"author":{"name":"fasihsheikh","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8"},"headline":"Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding","datePublished":"2023-03-12T15:56:57+00:00","dateModified":"2023-03-12T15:56:58+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/"},"wordCount":233,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/","url":"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/","name":"Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding - Founder Lodge Latest News","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-03-12T15:56:57+00:00","dateModified":"2023-03-12T15:56:58+00:00","description":"Bicara Therapeutics, a Cambridge-based biotechnology research startup, has raised an impressive $108M in Series B funding from a range of investors","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/bicara-therapeutics-a-biotechnology-research-startup-has-raised-an-impressive-108m-in-series-b-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Bicara Therapeutics, a biotechnology research startup, has raised an impressive $108M in Series B funding"}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/476f6d3ed027a181b204c3cc272d73f8","name":"fasihsheikh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f911bcb98040d3fbae6f7d7e8b28246d?s=96&d=mm&r=g","caption":"fasihsheikh"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/fasihsheikh\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1773"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=1773"}],"version-history":[{"count":2,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1773\/revisions"}],"predecessor-version":[{"id":1778,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1773\/revisions\/1778"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/1776"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=1773"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=1773"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=1773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}